Robert Kulik

Robert Kulik is an experienced professional in market access and government affairs within the biopharma sector. Currently serving as the Director of Patient Value and Access at Elvium since February 2023, Kulik has held various key roles, including Principal at KMAS Consulting and Associate Director of Market Access at Dompé Canada. Previous positions include Director of Government Affairs at Teva Canada and Senior Partner at Accelera Canada, where expertise in market entry strategies, regulatory matters, and stakeholder engagement was utilized. Kulik has also served as Principal Consultant at Patient Access Solutions Inc. and has a history of leadership at Vertex Pharmaceuticals, EMD Serono, Genzyme Canada, and Biogen Idec Canada Inc. Academic credentials include a Master’s degree in Political Studies from the University of Guelph and a Bachelor’s degree in Political Science from York University.